Ultragenyx Pharmaceutical
RARE
RARE
151 hedge funds and large institutions have $3.33B invested in Ultragenyx Pharmaceutical in 2015 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 57 increasing their positions, 40 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
20% more funds holding
Funds holding: 126 → 151 (+25)
45% less call options, than puts
Call options by funds: $6.53M | Put options by funds: $11.9M
Holders
151
Holding in Top 10
3
Calls
$6.53M
Puts
$11.9M
Top Buyers
| 1 | +$83.7M | |
| 2 | +$69.8M | |
| 3 | +$32.5M | |
| 4 |
WC
Weatherbie Capital
Boston,
Massachusetts
|
+$26.6M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$22.9M |
Top Sellers
| 1 | -$102M | |
| 2 | -$51M | |
| 3 | -$45M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$33.3M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
-$30.7M |